ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CELL TRANSPORT;
CHEMICAL REACTION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CRYSTAL STRUCTURE;
CYTOTOXICITY;
DRUG SYNTHESIS;
ELECTROSPRAY MASS SPECTROMETRY;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
LIPOPHILICITY;
NUCLEAR MAGNETIC RESONANCE;
PRIORITY JOURNAL;
X RAY DIFFRACTION;
Boron neutron capture therapy of cancer: Current status and future prospects
DOI 10.1158/1078-0432.CCR-05-0035
RF Barth JA Coderre MGH Vicente TE Blue 2005 Clin Cancer Res 11 3987 4002 1:CAS:528:DC%2BD2MXks1Gksr4%3D 10.1158/1078-0432.CCR-05-0035 15930333 (Pubitemid 40791562)
Boronated DNA-binding compounds as potential agents for boron neutron capture therapy
DOI 10.2174/138955707780059808
EL Crossley EJ Ziolkowski JA Coderre LM Rendina 2007 Mini Rev Med Chem 7 303 313 1:CAS:528:DC%2BD2sXitVOitLw%3D 10.2174/138955707780059808 17346220 (Pubitemid 46488251)
AH Soloway W Tjarks BA Barnum F-G Rong RF Barth IM Codogni JG Wilson 1998 Chem Rev 98 1515 1562 1:CAS:528:DyaK1cXjtlygtL8%3D 10.1021/cr941195u 11848941
The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations
DOI 10.1016/S0304-3835(03)00274-X
JS Modica-Napolitano R Nalbandian ME Kidd A Nalbandian CC Nguyen 2003 Cancer Lett 198 59 68 1:CAS:528:DC%2BD3sXlvVSrsLs%3D 10.1016/S0304-3835(03) 00274-X 12893431 (Pubitemid 37289104)
Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines: Mitochondrial implication in cell death
DOI 10.1016/j.leukres.2005.03.014, PII S0145212605001542
E Galeano E Nieto I Garcia-Perez Ana MD Delgado M Pinilla P Sancho 2005 Leuk Res 29 1201 1211 1:CAS:528:DC%2BD2MXos1ahsb8%3D 10.1016/j.leukres.2005.03. 014 15893819 (Pubitemid 41169237)
MJ Weiss JR Wong CS Ha R Bleday RR Salem GD Steele LB Chen 1987 Proc Natl Acad Sci USA 84 5444 5448 1:CAS:528:DyaL2sXls1ygtL8%3D 10.1073/pnas.84.15.5444 3474661
Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes
DOI 10.1016/0006-2952(93)90144-L
WM Anderson DL Delinck L Benninger JM Wood ST Smiley LB Chen 1993 Biochem Pharmacol 45 691 696 1:CAS:528:DyaK3sXhs1aqtLY%3D 10.1016/0006-2952(93)90144-L 8442768 (Pubitemid 23064576)
Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT
DOI 10.1007/s11060-005-9099-4
K Yokoyama S-I Miyatake Y Kajimoto S Kawabata A Doi T Yoshida T Asano M Kirihata K Ono T Kuroiwa 2006 J Neuro Oncol 78 227 232 1:CAS:528: DC%2BD28Xpt1ylt70%3D 10.1007/s11060-005-9099-4 (Pubitemid 44018815)
JF Valliant KJ Guenther AS King P Morel P Schaffer OO Sogbein KA Stephenson 2002 Coord Chem Rev 232 173 230 1:CAS:528:DC%2BD38XntF2kur8%3D 10.1016/S0010-8545(02)00087-5
KL Bergeron EL Murphy O Majofodun LD Munoz JC Williams Jr KH Almeida 2009 Mutat Res Genet Toxicol Environ Mutagen 673 141 148 1:CAS:528: DC%2BD1MXivVeku7Y%3D 10.1016/j.mrgentox.2009.01.002
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
DOI 10.1016/j.canlet.2005.06.051, PII S0304383505009225, Pharmacogenomics in Cancer Chemotherapy: Recent Advances in Drug Transporters and Genome Analysis
R Kerb 2006 Cancer Lett 234 4 33 1:CAS:528:DC%2BD28Xit12itL8%3D 10.1016/j.canlet.2005.06.051 16504381 (Pubitemid 43343938)
TU Probst NG Berryman P Lemmen L Weissfloch T Auberger D Gabel J Carlsson B Larsson 1997 J Anal At Spectrom 12 1115 1122 1:CAS:528:DyaK2sXmslars7w%3D 10.1039/a700445a
Determination of boron in serum, plasma and urine by inductively coupled plasma mass spectrometry (ICP-MS). Use of mannitol-ammonia as diluent and for eliminating memory effect
DOI 10.1039/a908250f
D-H Sun R-L Ma CW McLeod X-R Wang AG Cox 2000 J Anal At Spectrom 15 257 261 1:CAS:528:DC%2BD3cXhtlGqsbo%3D 10.1039/a908250f (Pubitemid 30567319)
